Inhibikase Therapeutics, Inc. (IKT) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Inhibikase Therapeutics, Inc. (IKT) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $120.7M, listed on NASDAQ, employing roughly 15 people, carrying a beta of 0.96 to the broader market. Inhibikase Therapeutics, Inc. Led by Mark T. Iwicki, public since 2020-12-23.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for IKT as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →